Which forms of Philadelphia chromosome-positive chronic myelogenous leukaemia can nilotinib treat in adults and children?

Nilotinib treats Philadelphia chromosome-positive CML in adults and children with newly diagnosed chronic-phase disease or chronic-phase disease resistant or intolerant to prior therapy including imatinib, and adults with similarly resistant or intolerant accelerated-phase disease; efficacy data in blast crisis are unavailable.